Clinical Trial Collaborations
The Clinical Trial Collaborations (CTC) conference focuses on arguably the most important change in drug development: How we are altering the way we collaborate to drive greater efficiencies in productivity and bring us closer to the patient.
At the 2nd annual CTC event, we present a wide variety of sessions, which demonstrate new ways of collaborating for improved clinical trial outcomes as well as addressing how to strike a better balance in the delivery model for effective drug development.
We are pleased to announce that the 2017 conference opens with Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, on how the Clinical Collaborations Landscape is Changing and its Impact on R&D Operations.
Also confirmed to keynote is Dr Andy Plump, Director, Chief Medical & Scientific Officer, Takeda and Dr Steve Cutler, COO and CEO Designate, ICON. We are delighted to welcome back Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly, as co-chair. New to the program, Judith Dunn, VP, Global Head of Clinical Development and Head, Innovation Center, Roche, will lead an interactive session identifying technology needs and solutions.Immediately following this session is a fireside keynote discussion with Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, who joins Ken in an honest and open discussion on Models for Exquisite Project Delivery with Internal and External Partners.